339 related articles for article (PubMed ID: 19808894)
1. Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis.
Jager J; Grémeaux T; Gonzalez T; Bonnafous S; Debard C; Laville M; Vidal H; Tran A; Gual P; Le Marchand-Brustel Y; Cormont M; Tanti JF
Diabetes; 2010 Jan; 59(1):61-70. PubMed ID: 19808894
[TBL] [Abstract][Full Text] [Related]
2. The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions.
Berthou F; Ceppo F; Dumas K; Massa F; Vergoni B; Alemany S; Cormont M; Tanti JF
Mol Endocrinol; 2015 Jul; 29(7):1025-36. PubMed ID: 26020725
[TBL] [Abstract][Full Text] [Related]
3. Implication of the Tpl2 kinase in inflammatory changes and insulin resistance induced by the interaction between adipocytes and macrophages.
Ceppo F; Berthou F; Jager J; Dumas K; Cormont M; Tanti JF
Endocrinology; 2014 Mar; 155(3):951-64. PubMed ID: 24424060
[TBL] [Abstract][Full Text] [Related]
4. MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.
Ballak DB; van Essen P; van Diepen JA; Jansen H; Hijmans A; Matsuguchi T; Sparrer H; Tack CJ; Netea MG; Joosten LA; Stienstra R
PLoS One; 2014; 9(2):e89615. PubMed ID: 24586913
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of Beta-3 adrenergic receptor at serine 247 by ERK MAP kinase drives lipolysis in obese adipocytes.
Hong S; Song W; Zushin PH; Liu B; Jedrychowski MP; Mina AI; Deng Z; Cabarkapa D; Hall JA; Palmer CJ; Aliakbarian H; Szpyt J; Gygi SP; Tavakkoli A; Lynch L; Perrimon N; Banks AS
Mol Metab; 2018 Jun; 12():25-38. PubMed ID: 29661693
[TBL] [Abstract][Full Text] [Related]
6. Tpl2 contributes to IL-1β-induced IL-8 expression via ERK1/2 activation in canine dermal fibroblasts.
Naruke A; Nakano R; Nunomura J; Suwabe Y; Nakano M; Namba S; Kitanaka T; Kitanaka N; Sugiya H; Nakayama T
PLoS One; 2021; 16(11):e0259489. PubMed ID: 34735542
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
Loniewski KJ; Patial S; Parameswaran N
Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
[TBL] [Abstract][Full Text] [Related]
8. The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation.
Senger K; Pham VC; Varfolomeev E; Hackney JA; Corzo CA; Collier J; Lau VWC; Huang Z; Hamidzhadeh K; Caplazi P; Peng I; Setiadi AF; Francis R; Paler-Martinez A; Kwon YC; Ramirez-Carrozzi V; Sun Y; Grigg PW; Roose-Girma M; Jeet S; Barck KH; Pham A; Ota N; Ha C; Stinson J; Guillory J; Tam L; Modrusan Z; Emson C; McKenzie BS; Townsend MJ; Carano RAD; Warming S; Vucic D; DeVoss J; Lee WP; Lill JR; Zarrin AA
Sci Signal; 2017 Apr; 10(475):. PubMed ID: 28420753
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes.
Lagathu C; Yvan-Charvet L; Bastard JP; Maachi M; Quignard-Boulangé A; Capeau J; Caron M
Diabetologia; 2006 Sep; 49(9):2162-73. PubMed ID: 16865359
[TBL] [Abstract][Full Text] [Related]
10. Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease.
Lancaster GI; Kowalski GM; Estevez E; Kraakman MJ; Grigoriadis G; Febbraio MA; Gerondakis S; Banerjee A
PLoS One; 2012; 7(6):e39100. PubMed ID: 22701749
[TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
Rodríguez-Calvo R; Serrano L; Coll T; Moullan N; Sánchez RM; Merlos M; Palomer X; Laguna JC; Michalik L; Wahli W; Vázquez-Carrera M
Diabetes; 2008 Aug; 57(8):2149-57. PubMed ID: 18443198
[TBL] [Abstract][Full Text] [Related]
12. Cell adhesion tunes inflammatory TPL2 kinase signal transduction.
Vougioukalaki M; Georgila K; Athanasiadis EI; Eliopoulos AG
Cell Mol Life Sci; 2022 Feb; 79(3):156. PubMed ID: 35218437
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory cytokine interleukin-1β suppresses cold-induced thermogenesis in adipocytes.
Goto T; Naknukool S; Yoshitake R; Hanafusa Y; Tokiwa S; Li Y; Sakamoto T; Nitta T; Kim M; Takahashi N; Yu R; Daiyasu H; Seno S; Matsuda H; Kawada T
Cytokine; 2016 Jan; 77():107-14. PubMed ID: 26556104
[TBL] [Abstract][Full Text] [Related]
14. Trichostatin A modulates thiazolidinedione-mediated suppression of tumor necrosis factor α-induced lipolysis in 3T3-L1 adipocytes.
Lu JC; Chang YT; Wang CT; Lin YC; Lin CK; Wu ZS
PLoS One; 2013; 8(8):e71517. PubMed ID: 23951179
[TBL] [Abstract][Full Text] [Related]
15. Phillyrin, a natural lignan, attenuates tumor necrosis factor α-mediated insulin resistance and lipolytic acceleration in 3T3-L1 adipocytes.
Kong P; Zhang L; Guo Y; Lu Y; Lin D
Planta Med; 2014 Jul; 80(11):880-6. PubMed ID: 24995500
[TBL] [Abstract][Full Text] [Related]
16. Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes.
Ozaki KI; Awazu M; Tamiya M; Iwasaki Y; Harada A; Kugisaki S; Tanimura S; Kohno M
Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E643-E651. PubMed ID: 26860984
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.
Jager J; Grémeaux T; Cormont M; Le Marchand-Brustel Y; Tanti JF
Endocrinology; 2007 Jan; 148(1):241-51. PubMed ID: 17038556
[TBL] [Abstract][Full Text] [Related]
18. Cot/tpl2 participates in the activation of macrophages by adiponectin.
Sanz-Garcia C; Nagy LE; Lasunción MA; Fernandez M; Alemany S
J Leukoc Biol; 2014 Jun; 95(6):917-30. PubMed ID: 24532642
[TBL] [Abstract][Full Text] [Related]
19. TPL2 Is a Key Regulator of Intestinal Inflammation in Clostridium difficile Infection.
Wang Y; Wang S; Kelly CP; Feng H; Greenberg A; Sun X
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29844241
[TBL] [Abstract][Full Text] [Related]
20. Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance.
Perfield JW; Lee Y; Shulman GI; Samuel VT; Jurczak MJ; Chang E; Xie C; Tsichlis PN; Obin MS; Greenberg AS
Diabetes; 2011 Apr; 60(4):1168-76. PubMed ID: 21346175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
